Are HNMT rs11558538 and AOC1 rs10156191 variants linked to reduced histamine clearance and histamine-related symptoms?

Molecular mechanisms of impaired clearance

• HNMT rs11558538 (Thr105Ile): This functional polymorphism causes a dose-dependent reduction in histamine N-methyltransferase (HNMT) enzymatic activity and protein stability. The threonine-to-isoleucine substitution destabilizes protein folding, accelerating proteasomal degradation and lowering intracellular substrate clearance.
• AOC1 rs10156191 (Thr16Met): This nonsynonymous missense mutation alters the structural integrity of diamine oxidase (DAO), the primary extracellular histamine-degrading enzyme. Carriers of the T (Met) allele exhibit significantly reduced plasma DAO levels and impaired catalytic efficiency, directly compromising the clearance of dietary and endogenous histamine.

Clinical evidence and symptom patterns

• Local vs. systemic manifestation: While both genetic variants impair biochemical clearance, they diverge in their clinical presentations due to tissue-specific expression.
• HNMT-related symptoms: Because HNMT is highly active in the bronchus and skin, the rs11558538 variant acts primarily as a localized risk factor. It is associated with increased susceptibility to bronchial hyper-responsiveness, asthma, and eczema, rather than systemic histamine intolerance (HIT).
• AOC1-related symptoms: Reduced DAO activity from the rs10156191 variant directly correlates with systemic HIT. This includes heightened susceptibility to migraines (especially in women), insomnia, NSAID hypersensitivity, and severe fibromyalgia-like symptoms, with clinical severity heavily mediated by dietary histamine load and overall gut mucosal health.

Bottom line

• The claim is fully supported for AOC1 and partially supported for HNMT; the AOC1 rs10156191 variant significantly reduces DAO activity to drive systemic histamine intolerance symptoms (such as migraines), while the HNMT rs11558538 variant reduces local histamine clearance to primarily elevate tissue-specific atopic risks like asthma.